The Boyden chamber assay showed that LIMK1/CDK5 significantly promoted the invasion of EAC, gastric cancer, and lung cancer cells in a phosphorylation‐dependent manner (Figure S9E,F, Supporting Information). Here, LIMK1 is linked to lung cancer.